Journal of Breast Cancer

Korean Breast Cancer Society (한국유방암학회)
권호 표지
DOI QR코드

DOI QR Code

Ellagic Acid Shows Different Anti-proliferative Effects Between the MDA-MB-231 and MCF-7 Human Breast Cancer Cell Lines

Kim, Hyun-Ah;Lee, Ryung-Ah;Moon, Byung-In;Choe, Kuk-Jin

  • Published : 20090600
⟨ Previous Next ⟩

Abstract

Purpose: It has been demonstrated ellagic acid can inhibit tumor growth. However, the mechanism that elicits the antiproliferative effect of ellagic acid is poorly understood. Our objective in this study was to evaluate the biological activity of ellagic acid by comparing the anti-proliferative effect and the apoptotic pathway of ellagic acid between the 2 human breast cancer cell lines. Methods: The MCF-7 and MDAMB- 231 human breast cancer cell lines were used as cell models. The anti-proliferstive effect was evaluated by using a MTT assay. The cell cycle was analyzed by flow cytometry. Western blotting was performed to show the expressions of bcl-xL, cytochrome c, surviving, c-fos and pS2. Results: The ellagic acid in the MDA-MB-231 cells showed significant antiproliferative effects with dose dependent pattern. The antiproliferative effects in MCF-7 cells were observed in only at a high concentration. Ellagic acid had no effect on the cell cycle in both breast cancer cells. In MDA-MB-231, the expression of bcl-xL was decreased with the decreasing concentration of ellagic acid. The expression of cytochrome c in the cytosol was increased with the decreased expression of bcl-xL. Ellagic acid also decreased the expression of survivin. In the MCF-7 cells, the expressions of bcl-xL and cytochrome c showed no change after treatment with ellagic acid even at a high dose. Ellagic acid was able to induce an up-regulation of c-fos and pS2 protein in MCF-7. Conclusion: Ellagic acid has an anti-proliferative effect in the MDA-MB- 231 cells. This effect of ellagic acid is through the intrinsic pathway in MDA-MB-231 cells. However, the expression of bcl-xL showed no change in the MCF-7 cells. Ellagic acid has a different anti-proliferative effect between the two human breast cancer cell lines.

Keywords

References

  1. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, et al. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 2004;134:613-7.
  2. Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica Granatum) for human breast cancer. Breast Cancer Res Treat 2002;71:203-17. https://doi.org/10.1023/A:1014405730585
  3. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 2006;54:980-5. https://doi.org/10.1021/jf052005r
  4. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 2005;16:360-7. https://doi.org/10.1016/j.jnutbio.2005.01.006
  5. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758S-67S.
  6. Papoutsi Z, Kassi E, Tsiapara A, Fokialakis N, Chrousos GP, Moutsatsou P. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta. J Agric Food Chem 2005;53:7715-20. https://doi.org/10.1021/jf0510539
  7. Aggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 2004;1030:434-41. https://doi.org/10.1196/annals.1329.054
  8. Saleem A, Husheem M, Harkonen P, Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of terminalia chebula retz. fruit. J Ethnopharmacol 2002;81:327-36. https://doi.org/10.1016/S0378-8741(02)00099-5
  9. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC, et al. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 2005;25:971-9.
  10. Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 2005; 218:141-51. https://doi.org/10.1016/j.canlet.2004.06.007
  11. Smith WA, Freeman JW, Gupta RC. Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[ a,l]pyrene in the human breast cells MCF-7. Mutat Res 2001; 480-481:97-108. https://doi.org/10.1016/S0027-5107(01)00173-7
  12. Maciel ME, Castro GD, Castro JA. Inhibition of the rat breast cytosolic bioactivation of ethanol to acetaldehyde by some plant polyphenols and folic acid. Nutr Cancer 2004;49:94-9. https://doi.org/10.1207/s15327914nc4901_13
  13. Losso JN, Bansode RR, Trappey A 2nd, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 2004; 15:672-8. https://doi.org/10.1016/j.jnutbio.2004.06.004
  14. Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, et al. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 2005;26: 821-6. https://doi.org/10.1093/carcin/bgi024
  15. Larrosa M, Tomas-Barberan FA, Espin JC. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 2006;17:611-25. https://doi.org/10.1016/j.jnutbio.2005.09.004
  16. Bowes T, Singh B, Gupta RS. Subcellular localization of fumarase in mammalian cells and tissues. Histochem Cell Biol 2007;127:335-46. https://doi.org/10.1007/s00418-006-0249-3
  17. Tondera D, Santel A, Schwarzer R, Dames S, Giese K, Klippel A, et al. Knockdown of MTP18, a novel phosphatidylinositol 3-kinasedependent protein, affects mitochondrial morphology and induces apoptosis. J Biol Chem 2004;279:31544-55. https://doi.org/10.1074/jbc.M404704200
  18. Stearns V, Coop A, Singh B, Gallagher A, Yamauchi H, Lieberman R, et al. A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clin Cancer Res 2004;10:7583-91. https://doi.org/10.1158/1078-0432.CCR-04-0295
  19. Wagner JE, Huff JL, Rust WL, Kingsley K, Plopper GE. Perillyl alcohol inhibits breast cell migration without affecting cell adhesion. J Biomed Biotechnol 2002;2:136-40. https://doi.org/10.1155/S1110724302207020
  20. Nhan S, Anderson KE, Nagamani M, Grady JJ, Lu LJ. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women. Nutr Cancer 2005;53:73-81. https://doi.org/10.1207/s15327914nc5301_9
  21. Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O. Evidence of a lack of effect of a phytoestrogen regimen on the levels of Creactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 2003;88:5180-5. https://doi.org/10.1210/jc.2003-030362
  22. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 2006;54:1611-20. https://doi.org/10.1021/jf0527403
  23. Narayanan BA, Re GG. IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res 2001;21:359-64.
  24. Kuo PL, Hsu YL, Kuo YC, Chang CH, Lin CC. The anti-proliferative inhibition of ellipticine in human breast MDA-MB-231 Cancer cells is through cell cycle arrest and apoptosis induction. Anticancer Drugs 2005;16:789-95. https://doi.org/10.1097/01.cad.0000171768.36317.93
  25. Xiao D, Vogel V, Singh SV. Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol Cancer Ther 2006;5:2931-45. https://doi.org/10.1158/1535-7163.MCT-06-0396
  26. Ka H, Hunt JS. Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 2003;163:413-22. https://doi.org/10.1016/S0002-9440(10)63671-1
  27. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998;58:5315-20.
  28. Li QX, Zhao J, Liu JY, Jia LT, Huang HY, Xu YM, et al. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. Cancer Biol Ther 2006;5: 860-6. https://doi.org/10.4161/cbt.5.7.2893
  29. Rumjahn SM, Javed MA, Wong N, Law WE, Buxton IL. Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br J Cancer 2007;97:1372-80. https://doi.org/10.1038/sj.bjc.6604019
  30. Brown AM, Jeltsch JM, Roberts M, Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 1984;81: 6344-8. https://doi.org/10.1073/pnas.81.20.6344

Cited by

  1. Punica granatumand its therapeutic implications on breast carcinogenesis: A review : Punica granatum and breast carcinogenesis vol.41, pp.2, 2015, https://doi.org/10.1002/biof.1206
  2. Apoptotic efficacy of biogenic silver nanoparticles on human breast cancer MCF-7 cell lines vol.4, pp.2, 2009, https://doi.org/10.1007/s40204-015-0042-2
  3. Impact of Cellular Genetic Make-up on Colorectal Cancer Cell Lines Response to Ellagic Acid: Implications of small interfering RNA vol.17, pp.2, 2009, https://doi.org/10.7314/apjcp.2016.17.2.743
  4. Wild-growing Rosa heckeliana Tratt.: phenolic constituentswith cytotoxic and antioxidative properties vol.41, pp.None, 2009, https://doi.org/10.3906/biy-1605-89
  5. A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius vol.12, pp.1, 2009, https://doi.org/10.5897/jmpr2017.6518